Trabedersen
Intermediates
- Trabedersen is an antisense oligonucleotide therapy designed to inhibit TGF-β2 expression, investigated for the treatment of malignant tumors by reducing tumor growth and immune suppression. Reference standards of Trabedersen API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Trabedersen
[catalogue_number] => PA 20 4160000
[category_ids] => ,78,70,82,
[chemical_name] =>
[weight] => NA
[form] => NA
[cas] => 925681-61-4
[pslug] => 925681-61-4-trabedersen-pa204160000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
